Coronavirus and cancer hijack the same parts in human cells to spread – and our team identified existing cancer drugs that could fight COVID-19
Molecular Partners hopes for COVID-19 rebound after eye drug failure
Inovio adds two to the leadership team; Adrian Woolfson is out at Sangamo
3 Biotech Stocks Under $5 With 100%-Plus Upside Potential
Entos Pharmaceuticals announces selection of lead DNA vaccine candidates for COVID-19
3 Under-the-Radar Penny Stocks Gearing up for Gains
Top Analysts See 100%-Plus Upside Potential in These 3 Penny Stocks
Top Analysts Bet on These 3 Penny Stocks; See 100%-Plus Upside Potential
Biogeneration Ventures raises $119M for new fund, adding a personal record to series of VC raises
Pluristem Is a High Risk, High Reward Play, Says Jefferies Analyst
Sanofi Adds COVID-19, Flu Candidates to up to $2.3B+ mRNA Vaccine Partnership with Translate Bio
Sanofi, Translate Bio Ramp Up Billion-Dollar mRNA Vaccine Collaboration
Boehringer Ingelheim nabs new US president and CEO; AstraZeneca vet hops aboard Novavax as CMO
Exercise offers ‘profound’ benefits for Friedreich’s ataxia, research suggests
UK’s Imperial College begins trial of coronavirus vaccine
’Omics in Translation
Sorrento Edges Higher On Debt Repayment As Top Analyst Says Buy
The pandemic IPOs keep rolling, as Generation, Avidity, Vaxcyte each claim 200M+
Regeneron Starts Human Clinical Trials Of Covid-19 Antibody Cocktail
Lilly CSO: COVID-19 Antibody Treatment Could Be Ready by Fall 2020
Top Analyst Sees More Than One Path to COVID-19 Solutions for Sorrento
Sorrento Soars 17% In Pre-Market On Covid-19 Test Application
Lilly COVID-19 treatment could be authorized for use as soon as September
J&J’s Janssen Speeds Up Planned Launch of COVID-19 Vaccine Trial
Upcoming Korean COVID-19 Vaccine Trial Marks Key Milestone for Inovio (INO); 5-Star Analyst Says 'Buy'
Junshi Biosciences Kicks Off China’s First Covid-19 Antibody Trial
AbbVie Announces Partnership To Develop Novel Covid-19 Antibody Therapy
Novavax's COVID Vaccine Candidate Left off White House List; 5-Star Analyst Explains the Implications
iBio – IBIO-201
Sorrento Therapeutics and Mount Sinai Health System